1. 2022
  2. Resistance mechanisms to HER2-targeted therapy in gastroesophageal adenocarcinoma: A systematic review

    Blangé, D., Stroes, C. I., Derks, S., Bijlsma, M. F. & van Laarhoven, H. W. M., 1 Jul 2022, In: Cancer treatment reviews. 108, 102418.

    Research output: Contribution to journalReview articleAcademicpeer-review

  3. Body Composition Is a Predictor for Postoperative Complications After Gastrectomy for Gastric Cancer: a Prospective Side Study of the LOGICA Trial

    LOGICA Study Group, Jul 2022, In: Journal of gastrointestinal surgery. 26, 7, p. 1373-1387 15 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Effect of a pre-operative web-based dietary self-management intervention on patient satisfaction, body weight and quality of life of esophageal cancer patients: A prospective, observational study

    Adriaans, D. J. M., Beijer, S., Heesakkers, F. F. B. M., de Craen-Kat, L., Horevoorts, N., Dierick-van Daele, A., Teijink, J. A. W., van Laarhoven, H. W. M., van de Poll-Franse, L. & Nieuwenhuijzen, G. A. P., 1 Jun 2022, In: Clinical Nutrition Open Science. 43, p. 42-55 14 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer

    Slagter, A. E., Caspers, I. A., van Grieken, N. C. T., Walraven, I., Lind, P., Kranenbarg, E. M-K., Grootscholten, C., Nordsmark, M., van Sandick, J. W., Sikorska, K., van de Velde, C. J. H., Jansen, E. P. M., Verheij, M., van Laarhoven, H. W. M. & Cats, A., 1 Jun 2022, In: Cancers. 14, 12, 2963.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Turkish imams and their role in decision-making in palliative care: A Directed Content and Narrative analysis

    Muishout, G., Topcu, N., de la Croix, A., Wiegers, G. & van Laarhoven, H. W. M., 1 Jun 2022, In: Palliative medicine. 36, 6, p. 1006-1017 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients with Resectable or Borderline Resectable Disease (COMM-PACT-RB): A Systematic Review and Delphi Consensus Statement

    Pijnappel, E. N., Suurmeijer, J. A., Koerkamp, B. G., Kos, M., Siveke, J. T., Salvia, R., Ghaneh, P., van Eijck, C. H. J., van Etten-Jamaludin, F. S., Abrams, R., Brasiūnienė, B., Büchler, M. W., Casadei, R., van Laethem, J-L., Berlin, J., Boku, N., Conroy, T., Golcher, H., Sinn, M., Neoptolemos, J. P., & 4 othersvan Tienhoven, G., Besselink, M. G., Wilmink, J. W. & van Laarhoven, H. W. M., Jun 2022, In: JAMA oncology. 8, 6, p. 929-937 9 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  8. Narrative recognition and identification: a qualitative pilot study into reading literary texts with advanced cancer patients

    Kamp, A., Bood, Z., Scherer-Rath, M., Weeseman, Y., Christophe, N., Dörr, H., Sanders, J., Sprangers, M., Helmich, E., Timmermans, L., van Wolde, E. & van Laarhoven, H. W. M., Jun 2022, In: Journal of cancer survivorship. 16, 3, p. 531-541 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. The fear of cancer recurrence and progression in patients with pancreatic cancer

    Pijnappel, E. N., Dijksterhuis, W. P. M., Sprangers, M. A. G., Augustinus, S., de Vos-Geelen, J., de Hingh, I. H. J. T., Dutch Pancreatic Cancer Group, Molenaar, I. Q., Busch, O. R., Besselink, M. G., Wilmink, J. W. & van Laarhoven, H. W. M., Jun 2022, In: Supportive care in cancer. 30, 6, p. 4879-4887 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Treatment decision-making during outpatient clinic visit of patients with esophagogastric cancer. The perspectives of clinicians and patients, a mixed method, multiple case study

    Luijten, J. C. H. B. M., Brom, L., Vissers, P. A. J., van de Wouw, Y. A. J., Warmerdam, F. A. R. M., Heisterkamp, J., Mook, S., Oulad Hadj, J., van Det, M. J., Timmermans, L., Hulshof, M. C. C. M., van Laarhoven, H. W. M., Rosman, C., Siersema, P. D., Westerman, M. J., Verhoeven, R. H. A. & Nieuwenhuijzen, G. A. P., Jun 2022, In: Cancer medicine. 11, 12, p. 2427-2444 18 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  11. Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma

    the Dutch Pancreatic Cancer Group, 15 May 2022, In: International Journal of Cancer. 150, 10, p. 1654-1663

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...54 Next

ID: 97805